185 related articles for article (PubMed ID: 36929005)
21. [Exosomal FZD10 derived from non-small cell lung cancer cells promotes angiogenesis of human umbilical venous endothelial cells
Wu X; Zhan R; Cheng D; Chen L; Wang T; Tang X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1351-1358. PubMed ID: 36210708
[TBL] [Abstract][Full Text] [Related]
22. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
Clark DJ; Fondrie WE; Yang A; Mao L
J Proteomics; 2016 Feb; 133():161-169. PubMed ID: 26739763
[TBL] [Abstract][Full Text] [Related]
23. An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer.
Noguchi S; Saito A; Horie M; Mikami Y; Suzuki HI; Morishita Y; Ohshima M; Abiko Y; Mattsson JS; König H; Lohr M; Edlund K; Botling J; Micke P; Nagase T
Clin Cancer Res; 2014 Sep; 20(17):4660-72. PubMed ID: 24951773
[TBL] [Abstract][Full Text] [Related]
24. Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer.
Ma Z; Wei K; Yang F; Guo Z; Pan C; He Y; Wang J; Li Z; Chen L; Chen Y; Xia Y
Cell Death Dis; 2021 Sep; 12(9):840. PubMed ID: 34497265
[TBL] [Abstract][Full Text] [Related]
25. Sulfonylurea receptor 1-expressing cancer cells induce cancer-associated fibroblasts to promote non-small cell lung cancer progression.
Chen H; Zhao L; Meng Y; Qian X; Fan Y; Zhang Q; Wang C; Lin F; Chen B; Xu L; Huang W; Chen J; Wang X
Cancer Lett; 2022 Jun; 536():215611. PubMed ID: 35240233
[TBL] [Abstract][Full Text] [Related]
26. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
27. BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9.
Chen J; Ding C; Yang X; Zhao J
J BUON; 2021; 26(5):1832-1841. PubMed ID: 34761590
[TBL] [Abstract][Full Text] [Related]
28. Identification of neuroblastoma cell lines with uncommon TAZ
Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
30. YKT6 expression, exosome release, and survival in non-small cell lung cancer.
Ruiz-Martinez M; Navarro A; Marrades RM; Viñolas N; Santasusagna S; Muñoz C; Ramírez J; Molins L; Monzo M
Oncotarget; 2016 Aug; 7(32):51515-51524. PubMed ID: 27285987
[TBL] [Abstract][Full Text] [Related]
31. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
32. TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma.
Xu W; Wei Y; Li Y; Yin Y; Yuan W; Yang Y; Zhao W; Wu J
Oncol Rep; 2017 Sep; 38(3):1815-1821. PubMed ID: 28737828
[TBL] [Abstract][Full Text] [Related]
33. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Song Z; Jia G; Ma P; Cang S
Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
[TBL] [Abstract][Full Text] [Related]
34. PLA2G10 incorporated in exosomes could be diagnostic and prognostic biomarker for non-small cell lung cancer.
Chen Y; Ma X; Lou C; Zhou C; Zhao X; Li N; Tian H; Meng X
Clin Chim Acta; 2022 May; 530():55-65. PubMed ID: 35231479
[TBL] [Abstract][Full Text] [Related]
35. TAZ maintains telomere length in TNBC cells by mediating Rad51C expression.
Yang L; Wang B; Jiao X; Zhou C; Chen S; Gao X; Sun W; Song S; Li J; Liu J; Wang Y; Liu P
Breast Cancer Res; 2021 Sep; 23(1):89. PubMed ID: 34488828
[TBL] [Abstract][Full Text] [Related]
36. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
37. TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription.
Yuan W; Xu W; Li Y; Jiang W; Li Y; Huang Q; Chen B; Wu S; Wang Y; Song W; Zhao W; Wu J
Cell Death Dis; 2019 Mar; 10(4):283. PubMed ID: 30911072
[TBL] [Abstract][Full Text] [Related]
38. Cancer cell-derived exosomal circUSP7 induces CD8
Chen SW; Zhu SQ; Pei X; Qiu BQ; Xiong D; Long X; Lin K; Lu F; Xu JJ; Wu YB
Mol Cancer; 2021 Nov; 20(1):144. PubMed ID: 34753486
[TBL] [Abstract][Full Text] [Related]
39. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
40. Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer.
Liu S; Wang W; Ning Y; Zheng H; Zhan Y; Wang H; Yang Y; Luo J; Wen Q; Zang H; Peng J; Ma J; Fan S
Cell Death Dis; 2022 Feb; 13(2):129. PubMed ID: 35136028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
